Abstract
A clinically acceptable modified erythrocyte concentrate with long shelf-life can now be readily provided even after complete removal of all available plasma for fractionation. The concentrates have been evaluated in an uneventful clinical trial.
| Original language | English |
|---|---|
| Pages (from-to) | 635-637 |
| Number of pages | 3 |
| Journal | Medical Journal of Australia |
| Volume | 1 |
| Issue number | 12 |
| Publication status | Published - 1981 |